
Health Impact News – May 17, 2017
Today (May 17, 2022), the U.S. Food and Drug Administration (FDA) amended the emergency use authorization (EUA) and authorized a booster dose of the Pfizer-BioNTech COVID-19 shot for children 5 through 11 years of age. The booster shot is 10 micrograms, which is the same dosage for this age group in their primary series and a third of that given to people aged 12 and older.
Read more & video(29:28): “In Memorian Victims of COVID-19 “Vaccines”: https://healthimpactnews.com/2022/fda-authorizes-pfizer-booster-covid-shot-for-children-between-the-ages-of-5-and-11/
You must be logged in to post a comment.